Financhill
Sell
39

CABA Quote, Financials, Valuation and Earnings

Last price:
$2.20
Seasonality move :
-11.03%
Day range:
$2.12 - $2.20
52-week range:
$0.99 - $3.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.52x
Volume:
2.8M
Avg. volume:
2.3M
1-year change:
-6.41%
Market cap:
$211.3M
Revenue:
--
EPS (TTM):
-$2.53

Earnings Data

Next earnings date for CABA
Mar 30
2026
Most recent earnings per share
-$0.44
Beat by $0.02
(Nov 10/2025)
Consensus Estimate
-$0.46
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CABA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/30/2026 Q4 -- -- -- -$0.47 --
11/10/2025 Q3 -- -- -$0.44 -$0.46 $0.02
08/08/2025 Q2 $4.2M -- -$0.73 -$0.61 -$0.12
05/15/2025 Q1 -- -- -$0.71 -$0.66 -$0.05
03/31/2025 Q4 -- -- -$0.65 -$0.63 -$0.02
11/14/2024 Q3 -- -- -$0.62 -$0.61 -$0.01
08/08/2024 Q2 -- -- -$0.56 -$0.57 $0.01
05/15/2024 Q1 -- -- -$0.51 -$0.48 -$0.02
03/21/2024 Q4 -- -- -$0.47 -$0.39 -$0.08
11/09/2023 Q3 -- -- -$0.37 -- --
08/10/2023 Q2 -- -- -$0.37 -- --
05/11/2023 Q1 -- -- -$0.45 -- --
03/16/2023 Q4 -- -- -$0.53 -- --
11/10/2022 Q3 -- -- -$0.39 -- --
08/11/2022 Q2 -- -- -$0.45 -- --
05/12/2022 Q1 -- -- -$0.45 -- --
03/17/2022 Q4 -- -- -$0.49 -- --
11/01/2021 Q3 -- -- -$0.45 -- --
08/05/2021 Q2 -- -- -$0.45 -- --
05/03/2021 Q1 -- -- -$0.41 -- --
03/16/2021 Q4 -- -- -$0.39 -- --
11/10/2020 Q3 -- -- -$0.35 -- --
08/06/2020 Q2 -- -- -$0.34 -- --
05/12/2020 Q1 -- -- -$0.31 -- --
03/30/2020 Q4 -- -- -$0.22 -- --
09/30/2019 Q3 -- -- -$0.19 -- --
06/30/2019 Q2 -- -- -$0.23 -- --
03/31/2019 Q1 -- -- -$0.61 -- --
12/31/2018 Q4 -- -- -$0.13 -- --
09/30/2018 Q3 -- -- -$0.39 -- --

Cabaletta Bio, Inc. Earnings Questions

  • How Much did Cabaletta Bio, Inc. Generate in Revenue Last Quarter?

    Cabaletta Bio, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Cabaletta Bio, Inc. Beat Earnings Last Quarter?

    Cabaletta Bio, Inc. announced earnings per share of -$0.44 which represents a beat of analyst forecast a -$0.46 per share.

  • Is Cabaletta Bio, Inc. Profitable?

    Cabaletta Bio, Inc. reported -$345K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Cabaletta Bio, Inc. EPS Next Year?

    Cabaletta Bio, Inc.'s earnings are forecast to decrease from -$2.34 per share to -$2.21 per share next year representing a decrease of -10.06%.

  • When is Cabaletta Bio, Inc.'s Earnings Date?

    Cabaletta Bio, Inc.'s next earnings date is March 30, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock